Alimuddin Zumla Zambian physician
Zumla, Alimuddin
Zumla, Alimuddin I.
Zumla, Alimuddin, 1955-
VIAF ID: 41995147 (Personal)
Permalink: http://viaf.org/viaf/41995147
Preferred Forms
- 100 0 _ ‡a Alimuddin Zumla ‡c Zambian physician
- 200 _ | ‡a Zumla ‡b Alimuddin
- 100 1 _ ‡a Zumla, Alimuddin
-
- 100 1 _ ‡a Zumla, Alimuddin
- 100 1 _ ‡a Zumla, Alimuddin
- 100 1 _ ‡a Zumla, Alimuddin
- 100 1 _ ‡a Zumla, Alimuddin
-
-
-
-
-
-
4xx's: Alternate Name Forms (14)
Works
Title | Sources |
---|---|
AIDS and respiratory medicine | |
Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic | |
The granulomatous disorders | |
Handbook of refugee health : for healthcare professionals and humanitarians providing care to forced migrants | |
Increased Cortisol | |
Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results | |
Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea | |
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections | |
Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009. | |
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future | |
Is the eradication of tuberculosis 'yesterday's ambition' or 'tomorrow's triumph'? | |
Is the Gulf War syndrome an immunologically mediated phenomenon? | |
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? | |
Isolation of Campylobacter species from Zambian patients with acute diarrhoea. | |
Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground | |
Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vacc | |
LEGIONNAIRES' DISEASE: EARLY LESSONS FROM 1988 LONDON OUTBREAK | |
Leprosy trends in Zambia 1991-2009. | |
Lessons for tuberculosis from scrutiny of HIV/AIDS and Malaria UK Parliamentary Questions | |
Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems | |
Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient. | |
Local regulation of glucocorticoid activity in sites of inflammation. Insights from the study of tuberculosis. | |
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology | |
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. | |
Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks | |
Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study | |
Lung remodeling in pulmonary tuberculosis | |
Making DOTS succeed | |
Malaria in spite of chemoprophylaxis | |
Malaria prophylaxis--a persisting dilemma. | |
Manson's tropical diseases | |
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma | |
Mass gatherings medicine: international cooperation and progress | |
Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events | |
MCQs for the MRCP part 1, c1993: | |
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network | |
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies | |
Middle East respiratory syndrome. | |
Mimics of sarcoidosis. Leprosy | |
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries | |
Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage. | |
Modulation of cell death by M. tuberculosis as a strategy for pathogen survival | |
Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era | |
Moving to research partnerships in developing countries | |
Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011. | |
Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis | |
Mycobacterium vaccae | |
Mycotic aneurysms: a case report, clinical review and novel imaging strategy | |
Necropsies in African children: consent dilemmas for parents and guardians | |
Neonatal sepsis and antibiotic resistance in developing countries | |
Neuropathology and Inflammatory Cell Characterization in 10 Autoptic COVID-19 Brains | |
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. | |
New developments in the epidemiology, diagnosis, treatment and prevention of respiratory tract infections | |
New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future | |
New global estimates of malaria deaths | |
New tools for achieving tuberculosis control: progress and reflexion | |
New tuberculosis diagnostics and rollout | |
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials | |
Non-randomised Ebola trials--lessons for optimal outbreak research | |
Non-tuberculous mycobacterial pulmonary infections. | |
Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment | |
Nosocomial transmission of tuberculosis in HIV/AIDS units in London | |
Nucleic acid detection and quantification in the developing world | |
Operational research and MDG tuberculosis control targets | |
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis | |
Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia | |
Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis | |
Parasites and HIV-related diarrhoea | |
The Return of the white plague : global poverty and the "new" tuberculosis | |
Tuberculosis : a comprehensive clinical reference | |
Tuberculosis : a subject collection from Cold Spring Harbor perspectives in medicine |